是或不是——一种肠促胰岛素还是肠抑胃素？
To be or not to be--an incretin or enterogastrone?
作者信息
Horowitz M, Nauck M A
机构信息
University of Adelaide, Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia 5005, Australia.
出版信息
Gut. 2006 Feb;55(2):148-50. doi: 10.1136/gut.2005.071787.
Abstract
Glucagon-like peptide 1 does not comfortably fulfil the criterion of a gut derived factor responsible for an enhanced meal related insulin response; it appears logical to add the definition of a "physiological incretin hormone".
摘要
胰高血糖素样肽-1并不完全符合作为一种负责增强与进餐相关胰岛素反应的肠道衍生因子的标准；添加“生理性肠促胰岛素激素”的定义似乎是合理的。
相似文献
1
To be or not to be--an incretin or enterogastrone?是或不是——一种肠促胰岛素还是肠抑胃素？
Gut. 2006 Feb;55(2):148-50. doi: 10.1136/gut.2005.071787.
2
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.内源性胰高血糖素样肽1控制人类胰腺内分泌分泌及胃窦-幽门-十二指肠运动。
Gut. 2006 Feb;55(2):243-51. doi: 10.1136/gut.2004.059741. Epub 2005 Jun 28.
3
Gastric emptying and release of incretin hormones after glucose ingestion in humans.人体摄入葡萄糖后胃排空及肠促胰岛素激素的释放
J Clin Invest. 1996 Jan 1;97(1):92-103. doi: 10.1172/JCI118411.
4
Is glucagon-like peptide 1 an incretin hormone?胰高血糖素样肽-1是一种肠促胰岛素激素吗？
Diabetologia. 1999 Mar;42(3):373-9. doi: 10.1007/s001250051165.
5
The gastrointestinal tract and glucose tolerance.
Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):479-84. doi: 10.1097/01.mco.0000134375.01310.97.
6
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.内源性胰高血糖素样肽-1参与胃动力和胰腺内分泌分泌的调节。
Scand J Gastroenterol. 2011 Apr;46(4):428-35. doi: 10.3109/00365521.2010.537680. Epub 2010 Nov 30.
7
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.胰高血糖素样肽-1功能障碍在肥胖中的作用及潜在治疗意义。
Diabetes Obes Metab. 2014 Jan;16(1):9-21. doi: 10.1111/dom.12119. Epub 2013 May 26.
8
Glucagon-like peptide-1 gastrointestinal regulatory role in metabolism and motility.胰高血糖素样肽-1 在胃肠道代谢和运动中的调节作用。
Vitam Horm. 2010;84:319-29. doi: 10.1016/B978-0-12-381517-0.00012-6.
9
Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.葡萄糖摄入后内源性胰高血糖素样肽-1对胰岛激素释放和胃排空的调节作用。
J Clin Endocrinol Metab. 2008 Dec;93(12):4909-16. doi: 10.1210/jc.2008-0605. Epub 2008 Sep 30.
10
GLP-1 regulates gastroduodenal motility involving cholinergic pathways.胰高血糖素样肽-1通过胆碱能途径调节胃十二指肠运动。
Neurogastroenterol Motil. 2009 Jun;21(6):609-18, e21-2. doi: 10.1111/j.1365-2982.2008.01246.x. Epub 2009 Feb 6.
引用本文的文献
1
Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards.胰高血糖素样肽-1受体激动剂与2型糖尿病的管理——回顾与展望
World J Diabetes. 2024 Mar 15;15(3):326-330. doi: 10.4239/wjd.v15.i3.326.
2
Central and Peripheral Fatigue Evaluation during Physical Exercise in Athletic Horses by Means of Raman Spectroscopy.通过拉曼光谱法评估运动马匹体育锻炼期间的中枢和外周疲劳
Animals (Basel). 2023 Jul 5;13(13):2201. doi: 10.3390/ani13132201.
3
Sugars, Sweet Taste Receptors, and Brain Responses.糖类、甜味受体与大脑反应。
Nutrients. 2017 Jun 24;9(7):653. doi: 10.3390/nu9070653.
4
Relationships between gastric emptying, postprandial glycemia, and incretin hormones.胃排空、餐后血糖与肠促胰岛素激素之间的关系。
Diabetes Care. 2013 May;36(5):1396-405. doi: 10.2337/dc12-1609.
5
Peripheral neural targets in obesity.肥胖症的周围神经靶点。
Br J Pharmacol. 2012 Jul;166(5):1537-58. doi: 10.1111/j.1476-5381.2012.01951.x.
6
Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function.胰高血糖素样肽-1（GLP-1）及基于肠促胰岛素的疗法对胃肠运动功能的影响。
Exp Diabetes Res. 2011;2011:279530. doi: 10.1155/2011/279530. Epub 2011 Jun 22.
7
Sensing via intestinal sweet taste pathways.通过肠道甜味通路进行感知。
Front Neurosci. 2011 Mar 3;5:23. doi: 10.3389/fnins.2011.00023. eCollection 2011.
8
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.外源性胰高血糖素样肽-1对危重症患者小肠营养物质血糖反应的影响：一项随机双盲安慰剂对照交叉研究。
Crit Care. 2009;13(3):R67. doi: 10.1186/cc7874. Epub 2009 May 13.
9
Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.外源性葡萄糖依赖性促胰岛素多肽会加重2型糖尿病患者的餐后高血糖。
Diabetes. 2009 Jun;58(6):1342-9. doi: 10.2337/db08-0958. Epub 2009 Mar 10.
10
Upper gastrointestinal function and glycemic control in diabetes mellitus.糖尿病患者的上消化道功能与血糖控制
World J Gastroenterol. 2006 Sep 21;12(35):5611-21. doi: 10.3748/wjg.v12.i35.5611.
本文引用的文献
1
Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.长效胰高血糖素样肽-1类似物利拉鲁肽（NN2211）对2型糖尿病患者血糖控制和体重的影响。
Diabet Med. 2005 Aug;22(8):1016-23. doi: 10.1111/j.1464-5491.2005.01567.x.
2
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.内源性胰高血糖素样肽1控制人类胰腺内分泌分泌及胃窦-幽门-十二指肠运动。
Gut. 2006 Feb;55(2):243-51. doi: 10.1136/gut.2004.059741. Epub 2005 Jun 28.
3
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.红霉素可拮抗胰高血糖素样肽1引起的胃排空减速，并在健康受试者中揭示其促胰岛素分泌作用。
Diabetes. 2005 Jul;54(7):2212-8. doi: 10.2337/diabetes.54.7.2212.
4
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.艾塞那肽（艾塞那肽-4）对二甲双胍治疗的2型糖尿病患者30周血糖控制及体重的影响。
Diabetes Care. 2005 May;28(5):1092-100. doi: 10.2337/diacare.28.5.1092.
5
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.胰高血糖素样肽1及其衍生物在糖尿病治疗中的应用
Regul Pept. 2005 Jun 15;128(2):135-48. doi: 10.1016/j.regpep.2004.07.014.
6
The physiological role of GLP-1 in human: incretin, ileal brake or more?胰高血糖素样肽-1在人体中的生理作用：肠促胰岛素、回肠制动，还是其他更多作用？
Regul Pept. 2005 Jun 15;128(2):109-15. doi: 10.1016/j.regpep.2004.06.018.
7
Glucagon-like peptide 1(GLP-1) in biology and pathology.生物学和病理学中的胰高血糖素样肽1（GLP-1）
Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):91-117. doi: 10.1002/dmrr.538.
8
Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.脂肪酶抑制对2型糖尿病患者高脂/高碳水化合物餐后胃排空以及血糖、胰岛素和心血管反应的影响。
Diabetologia. 2004 Dec;47(12):2208-14. doi: 10.1007/s00125-004-1591-4. Epub 2004 Dec 15.
9
Postprandial hyperglycemia and diabetes complications: is it time to treat?餐后高血糖与糖尿病并发症：是时候进行治疗了吗？
Diabetes. 2005 Jan;54(1):1-7. doi: 10.2337/diabetes.54.1.1.
10
Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes.小肠葡萄糖输送变化对健康受试者和2型糖尿病患者血糖、胰岛素及肠促胰岛素激素的影响。
J Clin Endocrinol Metab. 2004 Jul;89(7):3431-5. doi: 10.1210/jc.2004-0334.
Zotero 插件